Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iqvia Holdings Inc
(NY:
IQV
)
236.69
+2.80 (+1.20%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Iqvia Holdings Inc
< Previous
1
2
3
4
5
6
7
Next >
7 Hot Healthcare Stocks With the Potential to Outperform
February 15, 2023
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.
Via
InvestorPlace
Where IQVIA Hldgs Stands With Analysts
February 13, 2023
Via
Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
February 10, 2023
Via
Benzinga
PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday
February 10, 2023
With US futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Optimism Declines Slightly As Dow Drops 250 Points
February 10, 2023
The CNN Money Fear and Greed index showed some decline in the overall sentiment among US investors. US stocks closed lower on Thursday as investors assessed recent batch of corporate earnings.
Via
Benzinga
Earnings Outlook For IQVIA Holdings
February 09, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
January 23, 2023
Via
Benzinga
Analyst Ratings for IQVIA Hldgs
January 13, 2023
Via
Benzinga
Expert Ratings for IQVIA Hldgs
December 06, 2022
Via
Benzinga
Where IQVIA Hldgs Stands With Analysts
November 17, 2022
Via
Benzinga
Analyst Ratings for IQVIA Hldgs
November 17, 2022
Via
Benzinga
8 Analysts Have This to Say About IQVIA Hldgs
October 27, 2022
IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter:
Via
Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
February 07, 2023
These companies are changing their industries.
Via
The Motley Fool
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
January 17, 2023
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to...
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
January 11, 2023
These healthcare companies' revenue and earnings have grown, and they expect more growth.
Via
The Motley Fool
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
December 01, 2022
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
November 17, 2022
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.
Via
Benzinga
7 Analysts Have This to Say About IQVIA Hldgs
October 06, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Expert Ratings for IQVIA Hldgs
September 12, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
6 Analysts Have This to Say About IQVIA Hldgs
September 12, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday
October 27, 2022
Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%...
Via
Benzinga
What 5 Analyst Ratings Have To Say About IQVIA Hldgs
August 25, 2022
Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:
Via
Benzinga
5 Analysts Have This to Say About IQVIA Hldgs
August 25, 2022
Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Upgrades
Via
Benzinga
IQVIA: Q3 Earnings Insights
October 26, 2022
IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated...
Via
Benzinga
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
October 25, 2022
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.
Via
Investor's Business Daily
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
October 25, 2022
Biosimilars are bringing down prescription drug costs without sacrificing quality.
Via
The Motley Fool
Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%
October 06, 2022
HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.